openPR Logo
Press release

North America to be one of the key regions for the Difficile Infections (Clostridium Difficile Associated Disease) Treatment market | Says FMI Analyst

01-20-2023 04:07 PM CET | Health & Medicine

Press release from: Future Market Insights

Difficile Infections (Clostridium Difficile Associated Disease) Market

Difficile Infections (Clostridium Difficile Associated Disease) Market

The Difficile Infections (Clostridium Difficile Associated Disease) Treatment market is predicted to grow at a compound annual growth rate (CAGR) of 6% from 2023 to 2033 to reach a staggering valuation of US$ 1,448.75 Million. In 2023, the market is expected to surpass an impressive valuation of US$ 809 Million.

For more information: https://www.futuremarketinsights.com/reports/difficile-infections-clostridium-difficile-associated-disease-market

Clostridium difficile infection (CDI) is a disease caused by toxic compounds produced by the spore-forming bacteria "Clostridium difficile" found in the intestinal tract. It is one of the many causes of antibiotic-related diarrhea, with symptoms varying from mild, self-limiting diarrhea to severe diarrhea, pseudomembranous colitis, and potentially fatal fulminant colitis.

Utilization of antimicrobial drugs is expected to drive growth in the Clostridium difficile infection therapeutics market. Throughout the forecast timeframe, the aging global population is likely to drive the clostridium difficile infection treatment market. Moreover, contemporary lifestyles, sophisticated medical systems, and technological progress are expected to drive business growth in the coming years.

Request a Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-16263

Since the infection is becoming less common, the market for clostridium difficile infection treatments in European countries is shrinking. In Europe, the number of fatalities caused by healthcare-related CDI is estimated to be 3,700 per year. Because of the presence of mandatory monitoring, adherence to isolation, hygiene practices, and sanitation protocols, along with the tracking of antibiotic prescriptions, has advanced.

Key Takeaways from the Market Study

Global difficile infection treatment worth to reach US$ 1,448.75 Million by 2033
Clostridium difficile infection was most common in the United States, representing nearly 70% of all cases.
In Europe, the number of fatalities caused by healthcare-related CDI is estimated to be 3,700 per year.
Clostridium difficile infects approximately half a million North Americans each year, according to the Centers for Disease Control (CDC).
In North America, nearly 29,000 deaths occur within one month of being diagnosed with C. difficile.

Inquire Before Buying Research Report: https://www.futuremarketinsights.com/ask-question/rep-gb-16263

Market Competition

Key players in the clostridium infections (clostridium difficile associated disease) market are Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Pfizer, Inc., Actelion Pharmaceuticals, Alere, Inc., Trinity Biotech, Summit Therapeutics, Baxter International Inc., Sanofi S.A., Novartis AG, and AstraZeneca Plc.

Thermo ScientificTM XpectTM difficile Toxin A/B Test, launched by Thermo Fisher Scientific Inc. in September 2021, detects Clostridium difficile toxin A and B in human fecal specimens. It combines superior clinical efficiency with a straightforward three-step procedure.
The TOX A/B QUIK CHEK ® test from Tech Lab is a rapid enzymatic immunoassay that was released in February 2021. Antibodies against C. difficile toxins A and B are used in the test. A Response Window with two stripes is included in the device. A toxin A and B test line is denoted by one stripe. The monitoring line is the other striped line.

Key Segments Profiled in the Difficile Infections (Clostridium Difficile Associated Disease) Treatment Market Industry Survey 

By Treatment:

Antimicrobial Therapy
Faecal Microbiota Transplantation

By Drug Type:

Metronidazole
Vancomyci
Fidaxomicin

By End User:

Hospital
Pharmacies
ASCs

Buy Now/Purchase: https://www.futuremarketinsights.com/checkout/16263

By Region:

North America
Western Europe
Eastern Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release North America to be one of the key regions for the Difficile Infections (Clostridium Difficile Associated Disease) Treatment market | Says FMI Analyst here

News-ID: 2893626 • Views:

More Releases from Future Market Insights

Germany Powdered Soft Drinks Market Forecast: 3.5% CAGR Growth from 2025 to 2035
Germany Powdered Soft Drinks Market Forecast: 3.5% CAGR Growth from 2025 to 2035
The global powdered soft drinks market is set for significant expansion over the next decade, projected to grow from USD 13.1 billion in 2025 to approximately USD 18.3 billion by 2035, registering a compound annual growth rate (CAGR) of 3.4%. This growth is driven by evolving consumer preferences for convenient, on-the-go beverage solutions and a rising awareness of health and wellness. Powdered soft drink sales in Germany are projected to grow
Frozen Food Market Set to Reach USD 785.1 Billion by 2035, Driven by Convenience, Premiumization, and Technological Advancements
Frozen Food Market Set to Reach USD 785.1 Billion by 2035, Driven by Convenience …
The global frozen food market is poised for remarkable growth over the next decade, with its value projected to rise from USD 464.0 billion in 2025 to approximately USD 785.1 billion by 2035, reflecting an absolute increase of USD 321.1 billion and a compound annual growth rate (CAGR) of 5.4%. The expansion is being fueled by rising consumer demand for convenient, ready-to-eat meal solutions, the widespread adoption of advanced freezing
Global Food Emulsifiers Market Set to Reach USD 6.4 Billion by 2035, Driven by Clean-Label, Plant-Based, and Innovative Applications
Global Food Emulsifiers Market Set to Reach USD 6.4 Billion by 2035, Driven by C …
The global food emulsifiers market is poised for remarkable growth over the next decade. Valued at USD 4.1 billion in 2025, the market is projected to reach USD 6.4 billion by 2035, reflecting an absolute increase of USD 2.3 billion and a compound annual growth rate (CAGR) of 4.5%. This surge is driven by expanding food processing industries, rising consumer preference for convenient foods, and a growing emphasis on plant-based
Global Egg Protein Market Set to Reach USD 19 Billion by 2035, Driven by Clean-Label and Sports Nutrition Demand
Global Egg Protein Market Set to Reach USD 19 Billion by 2035, Driven by Clean-L …
The global egg protein market is poised for remarkable growth over the next decade, expanding from USD 10.1 billion in 2025 to an estimated USD 19.0 billion by 2035, reflecting a total growth of USD 8.9 billion and a CAGR of 6.5%. This surge is underpinned by rising consumer demand for high-protein, clean-label ingredients and increasing adoption across bakery, confectionery, sports nutrition, and dietary supplements. Full Market Report available for delivery.

All 5 Releases


More Releases for Difficile

Key Trend Reshaping the Difficile-Associated Diarrhea Treatment Market in 2025: …
What Are the Projections for the Size and Growth Rate of the Difficile-Associated Diarrhea Treatment Market? The difficile-associated diarrhea treatment market will grow from $3.27 billion in 2024 to $3.7 billion in 2025, at a CAGR of 13.2%. Growth factors include the prevalence of hospital-acquired infections, the aging population, and increasing cases of Clostridium difficile infections, as well as urbanization. The difficile-associated diarrhea treatment market is anticipated to experience rapid growth, reaching
Global Clostridium Difficile Immunoassays Market - Opportunities & Forecasts, 20 …
Dhirtek Business Research and Consulting recently released its most comprehensive research report to date on the global clostridium difficile immunoassays market. Through extensive research, analysts have provided an extensive look into the market's drivers and restraints, and identified the key milestones and trends that will shape its future. Primary and secondary research methods were used to create this in-depth report. Through the analysis of the research, Dhirtek was able
Personalized Genomics to Drive the Clostridium Difficile Infection Treatment Mar …
The Clostridium Difficile Infection Treatment Market is bound to grow robustly in the years to come. With smart technology and 5G being increasingly adopted, the healthcare vertical is witnessing a paradigm shift. These technologies can thus increase the convenience quotient (CQ), as abysmal disruption happens in the patients' lives. This convenience quotient would be the trend running in the healthcare vertical shortly. The critical need for non-antibiotic alternatives for prophylaxis and
The Clostridium Difficile Infection Treatment Market to Get Digitally Distilled
The Clostridium Difficile Infection Treatment Market is expected to grow on a healthy note in the subsequent decade. With value-based care picking up, close to 15% of the entire population is under its umbrella as of now. Programs like "Online Bachelor's Degree in General Studies with a Concentration in Healthcare" is being floated, which could aid professionals to lead in the value-based care strategies. In other words, the future belongs
Clostridium Difficile Infection Treatment Market Factors Influencing the Industr …
The market research report Clostridium Difficile Infection Treatment Market evaluates the historical, the latest values and current changes to predict the market for the coming years from 2019 to 2026. Our specific research examiners have been prepared to direct their exploration needs to the right research assets and to add a unique advantage over their rivals. We give scholarly, precise and important information in the lightning. The main actors focus their efforts
Clostridium Difficile Diagnostics and Treatment Market – Insights
Clostridium difficile is a disease caused by bacteria. Symptoms of the disease includes diarrhea, nausea, colon inflammation, and others. Clostridium difficile infection affects older adults, and according to Centers for Disease Control and Prevention (CDC), 2015, clostridium difficile infection is the most common healthcare-associated infection. Furthermore, frequent use of antibiotic medication is also responsible for clostridium difficile infection, as antibiotics kill normal flora (good bacteria) and allow for multiplication of